Bullous Pemphigoid
43
2
2
22
Key Insights
Highlights
Success Rate
81% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
11.6%
5 terminated out of 43 trials
81.5%
-5.0% vs benchmark
28%
12 trials in Phase 3/4
36%
8 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (43)
Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid
Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid
Autoimmune Blistering Diseases Study
Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid
A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
Efficacy and Safety of add-on Dapsone Versus add-on Methotrexate in Patients With Bullous Pemphigoid
Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid
Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.
JAK Inhibitors' Efficacy in Bullous Pemphigoid
Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid
Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
Retrospective Study of the Effects of Sub-pathologic Phenotypes of BP on Clinical Management and Prognosis
Pilot Efficacy and Safety Study of Oral DF2156A in Patients With Active Bullous Pemphigoid
Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid
Telederm and Bullous Pemphigoid